DHG Pharmaceutical JSC (DHG) — Cash Flow Quality Index
DHG Pharmaceutical JSC (DHG) has a Cash Flow Quality Index of 0.72x as of June 2026. Operating cash flow of ₫214.23 Billion is below net income of ₫298.67 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DHG operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DHG Pharmaceutical JSC Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for DHG Pharmaceutical JSC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of DHG Pharmaceutical JSC.
Annual Cash Flow Quality Index for DHG Pharmaceutical JSC (2019–2025)
Year-by-year earnings quality comparison for DHG Pharmaceutical JSC.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.42x | ₫1.21 Trillion | ₫852.35 Billion | ▼ -15.9% |
| 2024 | 1.69x | ₫1.32 Trillion | ₫778.92 Billion | ▲ +535.5% |
| 2023 | 0.27x | ₫279.88 Billion | ₫1.05 Trillion | ▼ -70.8% |
| 2022 | 0.91x | ₫901.28 Billion | ₫988.45 Billion | ▲ +56.6% |
| 2021 | 0.58x | ₫452.44 Billion | ₫777.22 Billion | ▼ -47.9% |
| 2020 | 1.12x | ₫826.17 Billion | ₫739.87 Billion | ▼ -15.4% |
| 2019 | 1.32x | ₫838.24 Billion | ₫635.39 Billion | — |